| Clinical Bottom Line: Pulmonary Embolism-Low molecular weight heparin is as effective as unfractionated heparin in decreasing recurrent VTE |
Citation: The Columbus Investigators. Low-molecular weight heparin in the treatment of patients with venous thromboembolism. NEJM 1997;337:657-62.
Three-part Question: In pts with PE, is low molecular weight heparin as effective as unfractionated heparin in decreasing recurrent venous thromboembolism?
Search Terms: "heparin", "pulmonary embolism" in MEDLINE
The Study:
Randomised controlled trial of consecutive pts with symptomatic DVT, PE or both; DVT could be in calf or proximal.
Controls (N=511) unfractionated heparin adjusted using a nomogram to a aPTT of 60-85s, coumadin started within first 48 hrs and continued for a total of 12 wks; heparin discontinued when INR >2 for 2 consecutive days
Experimental (N=510) low molecular weight heparin adjusted by pt weight, coumadin started within first 48 hrs and continued for a total of 12 wks; LMWH discontinued when INR >2 for 2 consecutive days
The Evidence:
|
Outcome |
Time to Outcome |
RRR |
95% CI |
ARR |
95% CI |
NNT |
95% CI |
|
recurrent VTE |
12 wks |
-8% |
-63% to 47% |
-0.004 |
-0.031 to 0.023 |
-250 |
NNH = 32 to INF; NNT = 43 to INF |
|
major bleed ( fall in haemo-globin of >2 or transfu-sion of 2 units) |
12 wks |
-35% |
-100% to 52% |
-0.008 |
-0.028 to 0.012 |
-125 |
NNH = 36 to INF; NNT = 84 to INF |
|
death |
12 wks |
7% |
-36% to 49% |
0.005 |
-0.027 to 0.037 |
200 |
NNH = 37 to INF; NNT = 27 to INF |
Comments:
Appraised by: Straus, Thursday, September 04, 1997
Expiry date: Sept/98
Click here to comment on this CAT |
![]() |